# Comparative, Randomized Study on the Anti-inflammatory and Regenerative Efficacy of a New Medical Device (DM) Based on Hydrolyzed Collagen Peptides in Patients With Femoro-acetabular Impingement Undergoing Hip Arthroscopy

> **NCT06082271** · NA · COMPLETED · sponsor: **Istituto Ortopedico Rizzoli** · enrollment: 25 (actual)

## Conditions studied

- Femoroacetabular Impingement
- Hip Arthroscopy
- Hip Osteoarthritis
- Hydrolyzed Collagen Peptides

## Interventions

- **DEVICE:** Class III medical Hydrolyzed Collagen Peptides PEP-52 (Peptys)
- **DRUG:** Cortisone

## Key facts

- **NCT ID:** NCT06082271
- **Lead sponsor:** Istituto Ortopedico Rizzoli
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-28
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-12-20
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06082271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06082271, "Comparative, Randomized Study on the Anti-inflammatory and Regenerative Efficacy of a New Medical Device (DM) Based on Hydrolyzed Collagen Peptides in Patients With Femoro-acetabular Impingement Undergoing Hip Arthroscopy". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06082271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*